How environmental toxins affect fat cell communication and inflammation
The Effects of Polychlorinated Biphenyls on Adipocyte-Macrophage Crosstalk
This study looks at how harmful chemicals called PCBs affect the way fat cells and immune cells work together in the body, which could help us understand how these toxins might play a role in obesity and type II diabetes.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10896560 on NIH RePORTER |
What this research studies
This research investigates the impact of polychlorinated biphenyls (PCBs), environmental toxins, on the interaction between fat cells and immune cells in the body. It focuses on how these toxins accumulate in adipose tissue and influence inflammation, which is linked to conditions like obesity and type II diabetes. By examining the communication between adipocytes and adipose tissue macrophages, the study aims to uncover the mechanisms by which PCBs disrupt metabolic health. Patients may gain insights into how environmental factors contribute to their metabolic conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with metabolic conditions such as obesity or type II diabetes, particularly those with potential exposure to PCBs.
Not a fit: Patients without metabolic disorders or those who have not been exposed to environmental toxins may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and management of metabolic diseases linked to environmental toxins.
How similar studies have performed: While the specific effects of PCBs on adipocyte-macrophage interactions are less explored, related research has shown that environmental toxins can significantly impact metabolic health.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Behan-Bush, Riley — University of Iowa
- Study coordinator: Behan-Bush, Riley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.